18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
Abstract
Gastrointestinal malignancies encompass a variety of primary tumor sites, each with
different staging criteria and treatment approaches. In this review we discuss technical
aspects of 18F-FDG-PET/CT scanning to optimize information from both the PET and computed
tomography components. Specific applications for 18F-FDG-PET/CT are summarized for
initial staging and follow-up of the major disease sites, including esophagus, stomach,
hepatobiliary system, pancreas, colon, rectum, and anus.
Type
Journal articleSubject
HumansGastrointestinal Neoplasms
Fluorodeoxyglucose F18
Radiopharmaceuticals
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Permalink
https://hdl.handle.net/10161/24155Published Version (Please cite this version)
10.1016/j.rcl.2021.06.001Publication Info
(2021). 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies. Radiologic clinics of North America, 59(5). pp. 737-753. 10.1016/j.rcl.2021.06.001. Retrieved from https://hdl.handle.net/10161/24155.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Brandon Augustus Howard
Assistant Professor of Radiology
Terence Z. Wong
Professor of Radiology
1. Anatomic/functional oncologic Imaging: SPECT/CT, PET/CT, novel PET radiotracers
2. Radiotheranostics, Radionuclide therapy of cancer, Radiation Therapy Planning 3.
Imaging biomarkers for guiding treatment strategies 4. Multicenter clinical trial
development (NCI National Clinical Trials Network)
Alphabetical list of authors with Scholars@Duke profiles.
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info